Letter to the Editor
Leukemia (2007) 21, 2384–2385; doi:10.1038/sj.leu.2404811; published online 21 June 2007
Lenalidomide as induction therapy before allogeneic stem cell transplantation in a patient with proliferative CMML-2 and del(5q) not involving the EGR1 locus
U Platzbecker1, B Mohr1, M von Bonin1, M Binder1, J Schetelig1, G Ehninger1 and M Bornhäuser1
1Medizinische Klinik und Poliklinik I, Universitätsklinikum Carl Gustav Carus, Dresden, Germany
Correspondence: U Platzbecker, E-mail: uwe.platzbecker@uniklinikum-dresden.de
Top of page
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
RESEARCH
Leukemia Letter
Leukemia Letter
Outcome of allo-SCT for chronic myelomonocytic leukemia
Bone Marrow Transplantation Letter
Bone Marrow Transplantation Original Article
